Coya Therapeutics, Inc. (COYA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 97.04M |
| Enterprise Value | 50.21M |
| P/E Ratio | -4.69 |
| PEG Ratio | 0.36 |
| Price/Sales Ratio | 12.36 |
| Price/Book Ratio | 1.84 |
| Enterprise/Revenue | 5.97 |
| Enterprise/EBITDA | -2.25 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -2.66 |
| Operating Margin | -2.77 |
| Return On Assets | -0.4 |
| Return On Equity | -0.57 |
| Revenue | 7.95M |
| Revenue/Share | 0.47 |
| Gross Profit | 7.92M |
| EBITDA | -21.2M |
| Net Income | -21.23M |
| Diluted EPS | -1.27 |
| Total Cash | 50.72M |
| Total Cash/Share | 3.03 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 15.02 |
| Book Value Per Share | 2.93 |
| 52-Week Change | -7.07 |
| 52-Week High | 7.75 |
| 52-Week Low | 3.71 |
| Moving Average 50 Days | 4.58 |
| Moving Average 200 Days | 5.19 |
| Average Volume | 166,700 |
| Shares Outstanding | 18.21M |
| % Held by Institutions | 48.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |